Future prospects for artificial blood

Trends in Biotechnology

Volumn 17, Issue 2, 1999, Pages 61-67

  Chang, Thomas M S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN; NITRIC OXIDE; OXYGEN RADICAL;

CROSS LINKING; ERYTHROCYTE; PRIORITY JOURNAL; REVIEW;

BIODEGRADATION, ENVIRONMENTAL; BLOOD SUBSTITUTES; CROSS-LINKING REAGENTS; DRUG CARRIERS; FORECASTING; HEMOGLOBINS; HUMANS; LIPIDS; OXIDANTS; RECOMBINANT PROTEINS;

EID: 0033079841     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(98)01242-6     Document Type: Review

References (89)

1. 1 Perutz, M. F. (1989) Trends Biochem. Sci. 14, 42-44
2. 2 Amberson, W. R. (1937) Biol. Rev. 12, 48-52
3. 3 Savitsky, J. P., Doozi, J., Black, J. and Arnold, J. D. (1978) Clin. Pharmacol. Ther. 23, 73-79
4. 4 Chang, T. M. S. (1964) Science 146, 524-525
5. 5 Bunn, H. F., Esham, W. T. and Bull, R. W. (1969) J. Exp. Med. 129, 909-924
6. 6 Chang, T.M.S. (1971) Biochem. Biophys. Res. Commun. 44, 1531-1533
7. 7 Chang, T. M. S. (1972) Artificial Cells, Charles C. Thomas, Springfield, IL, USA
8. 8 Benesch, R., Benesch, R. E., Renthal, R. D. and Maeda, N. (1972) Biochemistry 11, 3576-3582
9. 9 Dudziak, R. and Bonhard, K. (1980) Anesthetist 29, 181-189
10. 10 Gould, S. A. et al. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 12-28, Karger, Basel, Switzerland
11. 11 Gould, S. A. et al. (1998) J. Am. Cell. Surg. 187, 113-132
12. 12 Feola, M., Gonzales, P. C., Canizaro, D., Bingham, D. and Periman, D. (1983) Surg. Gynecol. Obstet. 147, 399-408
13. 13 Pearce, L. B. and Gawryl, M. S. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 82-98, Karger, Basel, Switzerland
14. 14 Hsia, J. C. (1989) US Patent No. 4 857 636
15. 15 Adamson, J. G. and Moore, C. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 62-79, Karger, Basel, Switzerland
16. 16 Walder, J. A. et al. (1979) Biochemistry 18, 4265-4270
17. 17 Nelson, D. J. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 39-57, Karger, Basel, Switzerland
18. 18 Hoffman, S. J. et al. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 8521-8525
19. 19 Freytag, J. W. and Templeton, D. (1997) in Red Cell Substitutes: Basic Principles and Clinical Application (Rudolph, A. S., Rabinovici, R. and Feuerstein, G. Z., eds), pp. 325-334, Marcel Dekker
20. 20 Tam, S. C., Blumenstein, J. and Wong, J. T. (1976) Proc. Natl. Acad. Sci. U. S. A. 73, 21-28
21. 21 Iwashita, Y. et al. (1988) Biomater. Artif. Cells Artif. Organs 16, 271-280
22. 22 Shum, K. L. et al. (1996) Artif. Cells Blood Subst. Immob. Biotechnol. 24, 655-683
23. 23 Feola, M. et al. (1988) Biomater. Artif. Cells Artif. Organs 16, 217-226
24. 24 Sekiguchi, S. (1992) Biomater. Artif. Cells Immob. Biotechnol. 20, 407-414
25. 25 Biessels, P. T. M. et al. (1992) Biomater. Artif. Cells Immob. Biotechnol. 20, 439-442
26. 26 Farmer, M. C. et al. (1992) Biomater. Artif. Cells Immob. Biotechnol. 20, 429-434
27. 27 Levin, J. et al. (1996) in Blood Substitutes: New Challenges (Winslow, R. M., Vandegriff, D. and Intaglietta, M., eds), pp. 185-202, Birkhäuser
28. 28 Fratantoni, J. C. (1991) Transfusion 31, 369-371
29. 29 Fratantoni, J. C. (1994) Transfusion 34, 712-713
30. 30 Chang, T. M. S. and Lister, C. W. (1993) US Patent No. 5 200 323
31. 31 Intaglietta, M., Johnson, P. C. and Winslow, R. M. (1996) Cardiovasc. Res. 32, 632-643
32. 32 Gulati, A., Sharma, A. C. and Singh, G. (1996) Crit. Care Med. 24, 137-147
33. 33 Kasper, S. M. et al. (1996) Anesth. Analg. 83, 921-927
34. 34 Abassi, Z. et al. (1998) Arch. Biochem. Biophys. 349, 65-73
35. 35 Doherty, D. H. et al. (1998) Nat. Biotechnol. 16, 672-677
36. 36 Chang, T. M. S., Lister, C., Nishiya, T. and Varma, R. (1992) Biomater. Artif. Cells Immob. Biotechnol. 20, 519-526
37. 37 Chang, T. M. S. (1997) Artif. Cells Blood Subst. Immob. Biotechnol. 25, 1-24
38. 38 Zuck, T. F. (1994) Artif. Cells Blood Subst. Immob. Biotechnol. 22, 945-954
39. 39 Winslow, R. M., Vandegriff, M. and Intaglietta, M., eds (1996) Blood Substitutes: New Challenges, Birkhäuser
40. 40 Hess, J. R. (1996) Curr. Opin. Hematol. 3, 492-497
41. 41 Waschke, K. F. et al. (1997) Acta Anaesthesiol. Scand. Suppl. 111, 259-263
42. 42 Dietz, N. M., Joyner, M. J. and Warner, M. A. (1996) Anesth. Analg. 82, 390-405
43. 43 Chang, T. M. S. (1997) Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. I), Karger, Basel, Switzerland
44. 44 Schreiber, G. B., Busch, M. P. and Kleinman, S. H. (1996) New Engl. J. Med. 334, 1685-1690
45. 45 Lackritz, E. M., Satten, G. A. and Aberle-Grasse, J. (1995) New Engl. J. Med. 333, 1721-1725
46. 46 Kumar, R. and Manjula, B. N. (1997) in Red Cell Substitutes: Basic Principles and Clinical Application (Rudolph, A. S., Rabinovici, R. and Feuerstein, G. Z., eds), pp. 309-324, Marcel Dekker
47. 47 O'Donnell, J. K. et al. (1992) Biomater. Artif. Cells Immob. Biotechnol. 20, 149
48. 48 Dieryck, W. et al. (1997) Nature 386, 29-30
49. 49 Komiyama, N., Tame, J. and Nagai, K. (1996) Biol. Chem. 377, 543-548
50. 50 Alayash, A. I. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 157-174, Karger, Basel, Switzerland
51. 51 Cashon, R. E. and Alayash, A. I. (1995) Arch. Biochem. Biophys. 316, 461-469
52. 52 Poli de Figueiredo, L. F. et al. (1997) Artif. Cells Blood Subst. Immob. Biotechnol. 25, 61-74
53. 53 Kluger, R. et al. (1992) Biochemistry 31, 7551-7559
54. 54 Bucci, E. et al. (1996) J. Lab. Clin. Med. 128, 146-153
55. 55 Jia, L. et al. (1996) Nature 380, 221-226
56. 56 D'Agnillo, F. and Chang, T. M. S. (1998) Nat. Biotechnol. 16, 667-671
57. 57 D'Agnillo, F. and Chang, T. M. S. (1997) US Patent No. 5 606 025
58. 58 Chang, T. M. S., D'Agnillo, F. and Razack, S. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 78-193, Karger, Basel, Switzerland
59. 59 Beaulieu, J. et al. (1998) J. Cereb. Blood Flow Metab. 18, 1022-1031
60. 60 Simoni, J. et al. (1997) Artif. Cells Blood Subst. Immob. Biotechnol. 25, 211-226
61. 61 Chang, T. M. S. (1988) Biomater. Artif. Cells Artif. Organs 16, 1-9
62. 62 Chang, T. M. S. and Poznansky, M. J. (1968) Nature 218, 242-245
63. 63 Chang, T. M. S. et al. (1967) Can. J. Physiol. Pharmacol. 45, 705-715
64. 64 Chang, T. M. S., MacIntosh, F. C. and Mason, S. G. (1971) Canadian Patent No. 873 815
65. 65 Djordjevich, L. and Miller, I. F. (1980) Exp. Hematol. 8, 584-586
66. 66 Bangham, A. D. and Horne, R. W. (1964) J. Mol. Biol. 8, 660-668
67. 67 Gaber, B. P. and Farmer, M. C. (1984) Prog. Clin. Biol. Res. 165, 179-190
68. 68 Hunt, A. C. et al., (1985) Science 230, 1165-1166
69. 69 Rudolph, A. S. and Phillips, W. T. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 197-205, Karger, Basel, Switzerland
70. 70 Rudolph, A. S., Rabinovici, R. and Feuerstein, G. Z., eds (1997) Red Blood Cell Substitutes, Marcel Dekker
71. 71 Tsuchida, E., ed. (1995) Artificial Red Cells, John Wiley & Sons
72. 72 Takaori, M. and Fukui, A. (1996) Artif. Cells Blood Subst. Immob. Biotechnol. 24, 643-653
73. 73 Beach, M. C., Morley, J., Spiryda, L. and Weinstock, S. B. (1998) Biomater. Artif. Cells Artif. Organs 16, 635-636
74. 74 Rollwagen, F. M. et al. (1996) Exp. Hematol. 24, 429-436
75. 75 Szebeni, J., Wassef, N. W., Rudolph, A. S. and Alving, C. R. (1996) Biochim. Biophys. Acta 1285, 127-130
76. 76 Usuba, A. et al. (1995) Artif. Cells Blood Subst. Immob. Biotechnol. 23, 337-346
77. 77 Vandegriff, K. D., Wallach, D. F. and Winslow, R. M. (1994) Artif. Cells Blood Subst. Immob. Biolechnol. 22, 849-854
78. 78 Chang, T. M. S. (1976) J. Bioeng. 1, 25-32
79. 79 Cedrati, N. et al. (1994) Artif. Cells Blood Subst. Immob. Biotechnol. 22, 867-873
80. 80 Chang, T. M. S. and Yu, W. P. (1992) UK Patent Application No. 92 194 265
81. 81 Yu, W. P. and Chang, T. M. S. (1994) Artif. Cells Blood Subst. Immob. Biotechnol. 22, 889-894
82. 82 Yu, W. P. and Chang, T. M. S. (1996) Artif. Cells Blood Subst. Immob. Biotechnol. 24, 169-184
83. 83 Chang, T. M. S. and Yu, W. P. (1997) US Patent No. 5 670 173
84. 84 Chang, T. M. S. and Yu, W. P. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 216-231, Karger, Basel, Switzerland
85. 85 Clark, L. C., Jr and Gollan, F. (1966) Science 152, 1755-1756
86. 86 Lowe, K. C., Davey, M. R. and Power, J. B. (1998) Trends Biotechnol. 16, 272-277
87. 87 Riess, J. G. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 101-126, Karger, Basel, Switzerland
88. 88 Keipert, P. E. (1998) in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II) (Chang, T. M. S., ed.), pp. 127-156, Karger, Basel, Switzerland
89. 89 Chang, T. M. S. (1992) Artif. Cells Blood Subst. Immob. Biotechnol. 20, 154-174